Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 12;9(5):496.
doi: 10.3390/vaccines9050496.

Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

Affiliations
Review

Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

Caroline Deignan et al. Vaccines (Basel). .

Abstract

Cervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are known to cause 70% of cervical cancers. Over the last five years, there has been an increase in Sub-Saharan African countries that have introduced the HPV vaccine. The majority of research has been conducted on supply-side barriers and facilitators to HPV vaccination uptake in SSA, yet little research has been conducted on demand-side or end-user perspectives of, and decisions around, HPV vaccination. In order to complement existing research, and inform current and future HPV vaccination implementation approaches, this qualitative systematic review explored Stakeholders' understandings of HPV vaccination in SSA. This review searched the following databases: Embase (via Scopus), Scopus, MEDLINE (via PubMed), PubMed, EBSCOhost, Academic Search Premier, Africa-Wide Information, CINAHL, PsycARTICLES, PsycINFO, SocINDEX, Web of Science, and the Cochrane Controlled Register of Trials (CENTRAL) and found a total of 259 articles. Thirty-one studies were found eligible for inclusion and were analyzed thematically using Braun and Clarke's methods for conducting a thematic analysis. The quality of included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklist. Three major themes emerged from this analysis; knowledge of HPV vaccination and cervical cancer is intertwined with misinformation; fear has shaped contradictory perceptions about HPV vaccination and gender dynamics are relevant in how stakeholders understand HPV vaccination in SSA.

Keywords: Human Papillomavirus (HPV); Sub-Saharan Africa (SSA); rapid qualitative systematic review; stakeholder understandings; thematic analysis; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA diagram of search strategy and results [20].
Figure 2
Figure 2
Included studies in thematic analysis mapped by country of origin (first author, year).

Similar articles

Cited by

References

    1. Bruni L., Barrionuevo-Rosas L., Albero G., Serrano B., Mena M., Gómez D., Muñoz J., Bosch F.X., de Sanjosé S. Human Papillomavirus and Related Diseases Report. [(accessed on 29 April 2021)]; Available online: https://hpvcentre.net/statistics/reports/XWX.pdf.
    1. CDC What Is HPV? [(accessed on 19 February 2020)]; Available online: https://www.cdc.gov/hpv/parents/whatishpv.html.
    1. WHO . Weekly Epidemiological Record. World Health Organization; Geneva, Switzerland: 2017. [(accessed on 29 April 2021)]. Human papillomavirus vaccines: WHO position paper. Record 12 May 2017. Available online: https://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf;jses....
    1. WHO Cervical Cancer Common Amongst African Women. World Health Organization. [(accessed on 29 April 2021)]; Available online: https://www.afro.who.int/news/cervical-cancer-common-amongst-african-women.
    1. WHO Human papillomavirus (HPV) [(accessed on 29 April 2021)]; Available online: https://www.who.int/immunization/diseases/hpv/en/